The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Gaf,
You may well get your buy in at 2.5p, but it's equally likely that you won't.
Yes the fundraising is dilutive, but it's also a show of support from "significant new institutional investors" and it's funding aimed at taking the company to revenues, where there was bankruptcy risk before there is now confidence that Quadrise succeed in executing their plan.
Plenty of IPO's don't drop loads, in fact the current trend seems to be 100%+ gain on IPO price on day 1.
As a comparison, AFC Energy (pre-revenue, small-cap AIM company) raised via a placing and a smaller open offer to shareholders last summer at 16p (which was much more of a discount at circa 25%), a few weeks later the price was 23p, it then dropped back to a low of 17p but never to 16p or below again. Within 6 months the SP was 80p+. Since dropped bac from there but my point is that we may never see prices below 2.7p again, its a gamble waiting for lower prices, and for me not worth the risk when a decent announcement could cause a significant re-rating here.
Also in Pertroteq and Tomco now, so yes, fingers crossed things pay off over there!
Back to QFI, we've already had some great news this year imho with the MSC partnership being announced and even without anything further (Morocco, Utah, Saudi?) all that needs to happen is for this to progress as planned and the SP will be multiples of where we are now by the this time next year. And long term holders will thoroughly deserve the gains.
Excited to hear progress from the company on Monday, get your questions in folks.
ATB
Techyrob im bullish. But 2.8p I will get more at 2.5p open offers are a sales pitch. Will see 2.5p. The dilution is to big to be proped up at 2.8p its a sales pitch. Look at ipo,s and open offers on companies they draw you in with free shares. And drop loads ,After that. I bought loads more petroteq yesterday that dropped lol. Let's just wait. But good news is whats needed. Its been a long time coming. And it better be good. Think a spike might happen. Maybe over 4p ,
tomco well 2p was a high last year. . And that won't be seen again at 0.46. God hope im wrong. Tomco is ageing me. I have far to much in that company. Look at that history to tell you thats is a diluted company thats ruined investors confidence. Fingers crossed. And qfi please deliver the goodies.